Position in PMVP
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$298,258
-$1,913 QoQ
Shares Held
240,531
+0.2% QoQ
Ownership
0.451%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Derivatives in PMVP
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$19,950
PutShares
1,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. PMVP ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in PMVP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $298,258 | 240,531 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $300,171 | 240,138 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $227,493 | 162,496 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $30,895 | 29,147 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,828 | 34,706 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,296 | 44,568 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $179,946 | 120,770 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $551,425 | 340,386 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,325,455 | 1,367,915 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,463,506 | 1,439,841 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $914,422 | 148,929 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,226,439 | 195,917 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,444,197 | 931,698 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,832,377 | 1,015,216 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,645,014 | 474,371 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,950 | 1,400 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $6,154,945 | 431,926 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,347,345 | 256,837 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,705,218 | 73,819 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $803,675 | 26,969 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,367,047 | 40,019 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,274,354 | 38,746 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $273,473 | 4,446 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $10,650 | 300 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||